Document is current
Any future updates will be listed below
-
Authors
Arshad, Muhammad Nauman
Bope, Christopher
Cho, Noell
Dengler, Jacob S.
Ng, Shu Fun Josephine
Smalley, Joshua L.
Nishi, Toshiya
Zhong, Zhong
Moss, Stephen J.
Davies, Paul A.
- License Information
-
More Information
Article History
Received: 8 June 2025
Revised: 31 October 2025
Accepted: 18 November 2025
First Online: 19 February 2026
Competing interests
: S.J.M. serves as a consultant for AstraZeneca, Ovid Therapeutics and Sage Therapeutics, relationships that are regulated by Tufts University. S.F.J.N. and S.J.M. hold equity in Ovid Therapeutics. T.N. and Z.Z. are employees of Ovid Therapeutics and hold equity. The other authors declare no competing interests.
